MX9703278A - Vacunas felinas que contienen chlamydia psittaci y metodo para preparar las mismas. - Google Patents

Vacunas felinas que contienen chlamydia psittaci y metodo para preparar las mismas.

Info

Publication number
MX9703278A
MX9703278A MX9703278A MX9703278A MX9703278A MX 9703278 A MX9703278 A MX 9703278A MX 9703278 A MX9703278 A MX 9703278A MX 9703278 A MX9703278 A MX 9703278A MX 9703278 A MX9703278 A MX 9703278A
Authority
MX
Mexico
Prior art keywords
making
same
vaccines containing
chlamydia psittaci
feline vaccines
Prior art date
Application number
MX9703278A
Other languages
English (en)
Other versions
MXPA97003278A (es
Inventor
Rebeca A Atherton
Norbert Schmeer
Jean A Hallstrom
Jennifer K Lane
Kristina J Hennessy
Original Assignee
Bayer Corp
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Corp, Bayer Ag filed Critical Bayer Corp
Publication of MX9703278A publication Critical patent/MX9703278A/es
Publication of MXPA97003278A publication Critical patent/MXPA97003278A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/118—Chlamydiaceae, e.g. Chlamydia trachomatis or Chlamydia psittaci
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/265—Infectious rhinotracheitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14311—Parvovirus, e.g. minute virus of mice
    • C12N2750/14334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

La presente invencion se relaciona con vacunas felinas que contiene una Chlamydia psittaci inactivada no reactiva para la prevencion y el tratamiento de enfermedades por clamidias en gatos.
MXPA/A/1997/003278A 1996-05-06 1997-05-06 Vacunas felinas que contienen chlamydia psittaci y metodo para preparar las mismas MXPA97003278A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08643673 1996-05-06
US08/643,673 US5972350A (en) 1996-05-06 1996-05-06 Feline vaccines containing Chlamydia psittaci and method for making the same

Publications (2)

Publication Number Publication Date
MX9703278A true MX9703278A (es) 1998-05-31
MXPA97003278A MXPA97003278A (es) 1998-10-23

Family

ID=

Also Published As

Publication number Publication date
EE9800388A (et) 1999-06-15
CZ360498A3 (cs) 1999-03-17
IL126628A (en) 2002-09-12
WO1997041889A1 (en) 1997-11-13
NO985172L (no) 1999-01-06
SK149198A3 (en) 2000-02-14
TR199802259T2 (xx) 1999-02-22
BG102890A (en) 1999-09-30
BG63564B1 (bg) 2002-05-31
EE04516B1 (et) 2005-08-15
BR9708975A (pt) 1999-08-03
IL126628A0 (en) 1999-08-17
CA2203234A1 (en) 1997-11-06
AU2996297A (en) 1997-11-26
NO320871B1 (no) 2006-02-06
AU717628B2 (en) 2000-03-30
CZ297848B6 (cs) 2007-04-11
EP0904106A1 (en) 1999-03-31
NO985172D0 (no) 1998-11-05
JP2000510121A (ja) 2000-08-08
PL329734A1 (en) 1999-04-12
NZ332620A (en) 2000-04-28
US5972350A (en) 1999-10-26

Similar Documents

Publication Publication Date Title
HK1015840A1 (en) Tissue products containing softeners and silicone glycol
EP1765179A4 (en) TISSUE REMOVAL DEVICE AND METHOD
ZA96740B (en) Skin treatment composition
AU5439996A (en) Compositions and methods for treating pain
GB9507130D0 (en) Hair treatment composition
IL117871A0 (en) Methods and formulations for modulating the human sexual response
GB2306469B (en) Sterilising cyanoacrylate preparations
EP0866683A4 (en) MEANS AND METHOD FOR TREATING DISEASE NAILS
ZA956993B (en) Methods of inhibiting demyelinating and desmyelinating diseases.
AU6522396A (en) Composition for cleaning or treating human or animal hair
GB9803642D0 (en) Hair treatment composition
GB9519033D0 (en) Treatment
IL111554A (en) Methods and compositions for hair treatment
IL113070A (en) Method of killing microorganisms
EP0747351A3 (en) Thiocationic lipids, pharmaceutical compositions and their methods of use
BG102890A (en) Vaccine for mammals of the feline family containing chlamydia prittaci, and a method for its preparation
GB2303303B (en) Medical treatment
IL124419A0 (en) Composition for treating pain
EP0845975A4 (en) HAIR TREATMENT
GB9526264D0 (en) Medical treatment
GB9525775D0 (en) Cosmetic hair treatment method
AU1554295A (en) Method for treatment and prevention of disease in animals
HU9402560D0 (en) Healing treatment for men and women
GB9507482D0 (en) Skin treatment composition
ZA968902B (en) Methods and compositions for treatment of diseases

Legal Events

Date Code Title Description
FG Grant or registration
MM Annulment or lapse due to non-payment of fees